Munar Pharma

Munar Pharma EV/Revenue

Delisted

The EV/Revenue (Enterprise Value to Revenue) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is 76.55. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 7.03 — a change of 988.71% (higher).

EV/Revenue

76.55

YoY

988.71%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of Munar Pharma is 2024 76.55 . EV/Revenue (Enterprise Value to Revenue) of Munar Pharma was 2023 7.03 . It decreases by 988.71% higher compared to the previous year.

The Munar Pharma EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2017
33.46 PLN
Jan 1, 2018
38.74 PLN
Jan 1, 2019
33.44 PLN
Jan 1, 2020
8.35 PLN
Jan 1, 2021
8.62 PLN
Jan 1, 2022
6.26 PLN
Jan 1, 2023
7.03 PLN
Jan 1, 2024
76.55 PLN
The Munar Pharma EV/Revenue history
YEAREV/RevenueYoY
76.55+988.71%
7.03+12.27%
6.26-27.38%
8.62+3.28%
8.35-75.03%
33.44-13.67%
38.74+15.79%
33.46+44.18%
23.20-7.78%
25.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

EV/Revenue (Enterprise Value to Revenue) of Munar Pharma is 76.55 in 2024.

EV/Revenue (Enterprise Value to Revenue) of Munar Pharma changed from 7.03 to 76.55, representing a 988.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Munar Pharma

All Key Metrics — Munar Pharma